Neurochemical evidence that lysine inhibits synaptic Na+,K +-ATPase activity and provokes oxidative damage in striatum of young rats in vivo

Neurochemical Research

Volumn 36, Issue 2, 2011, Pages 205-214

  Seminotti, Bianca ^a   Fernandes, Carolina Gonçalves ^a   Leipnitz, Guilhian ^a   Amaral, Alexandre Umpierrez ^a   Zanatta, Ângela ^a   Wajner, Moacir ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Lysine; Na+,K+ ATPase; Oxidative stress; Striatum

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; CITRIC ACID; CREATINE KINASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; LYSINE; MELATONIN; SCAVENGER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CITRIC ACID CYCLE; CONTROLLED STUDY; CORPUS STRIATUM; ENERGY METABOLISM; ENZYME ACTIVITY; ENZYME INHIBITION; IN VIVO STUDY; LIPID PEROXIDATION; NEUROCHEMISTRY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SYNAPSE;

ANIMALS; CORPUS STRIATUM; LYSINE; OXIDATION-REDUCTION; OXIDATIVE STRESS; RATS; RATS, WISTAR; SODIUM-POTASSIUM-EXCHANGING ATPASE; SYNAPSES; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

RATTUS;

EID: 78751618183     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-010-0302-4     Document Type: Article

References (69)

1. J Dancis J Hutzler RP Cox, et al. 1976 Multiple enzyme defects in familial hyperlysinemia Pediatr Res 10 686 691 1:CAS:528:DyaE28XkvFWmurw%3D 934735
2. Cox RP (2001) Errors of lysine metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill Inc, New York, pp 1965-1970
3. Cox RP, Dancis J (1995) Errors of lysine metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill Inc, New York, pp 1233-1238
4. RP Cox PJ Markovitz DT Chuang 1986 Familial hyperlysinemias-multiple enzyme deficiencies associated with the bifunctional aminoadipic semialdehyde synthase Trans Am Clin Climatol Assoc 97 69 81 1:STN:280:DyaL28zhsleguw%3D%3D 3939388
5. Hoffmann GF (2006) Cerebral organic acid disorders and other disorders of lysine catabolism. In: Fernandes J, Saudubray J-M, van den Berghe G, Walter JH (eds) Inborn metabolic diseases. Springer, Heidelberg, pp 293-306
6. NC Woody 1964 Hyperlysinemia Am J Dis Child 108 543 553 1:STN:280:DyaF2M%2FhsVSrsQ%3D%3D 14209691
7. H Ghadimi VI Binnington P Pecora 1965 Hyperlysinemia associated with retardation N Engl J Med 273 723 1:STN:280:DyaF28%2FgtFaitw%3D%3D 10.1056/NEJM196509302731401 5825685
8. MD Armstrong M Robinow 1967 A case of hyperlysinemia: biochemical and clinical observations Pediatrics 39 546 1:CAS:528:DyaF2sXktF2lu7g%3D 6022933
9. I Ozalp A Hasanoglu E Tuncbilek, et al. 1981 Hyperlysinemia without clinical findings Acta Pediatr Scand 70 951 953 1:STN:280:DyaL387htVWgsw%3D%3D 10.1111/j.1651-2227.1981.tb06259.x
10. JW Gregory N Beail NA Boyle, et al. 1989 Dietary treatment of hyperlysinaemia Arch Dis Child 64 716 720 1:STN:280:DyaL1M3nt1Wrsw%3D%3D 10.1136/adc.64.5.716 2499273
11. BT van Maldegem M Duran RJ Wanders, et al. 2006 Clinical, biochemical, and genetic heterogeneity in short-chain acyl-coenzyme A dehydrogenase deficiency JAMA 296 943 952 10.1001/jama.296.8.943 16926354 (Pubitemid 44285371)
12. C Battisti F Forte M Molinelli, et al. 2007 A new case of short-chain acyl-CoA dehydrogenase deficiency: clinical, biochemical, genetic and 1H-NMR spectroscopic studies Neurol Sci 28 328 330 1:STN:280:DC%2BD1c%2FgvV2jsw%3D%3D 10.1007/s10072-007-0847-4 18175080
13. I Tein O Elpeleg B Ben-Zeev, et al. 2008 Short-chain acyl-CoA dehydrogenase gene mutation (c.319C > T) presents with clinical heterogeneity and is candidate founder mutation in individuals of Ashkenazi Jewish origin Mol Genet Metab 93 179 189 1:CAS:528:DC%2BD1cXit1Sgs74%3D 10.1016/j.ymgme.2007.09. 021 18054510
14. SP Schmidt TJ Corydon CB Pedersen, et al. 2010 Misfolding of short-chain acyl-CoA dehydrogenase leads to mitochondrial fission and oxidative stress Mol Genet Metab 100 155 162 1:CAS:528:DC%2BC3cXmtFCmtrc%3D 10.1016/j.ymgme.2010.03. 009 20371198
15. CB Pedersen Z Zolkipli S Vang, et al. 2010 Antioxidant dysfunction: potential risk for neurotoxicity in ethylmalonic aciduria J Inherit Metab Dis 33 211 222 1:CAS:528:DC%2BC3cXmsFyjurs%3D 10.1007/s10545-010-9086-6 20443061
16. C Yiannikas D Cordato 1996 Familial hyperlysinemia in a patient presenting with progressive spastic paraparesis Neurology 47 846 1:STN:280:DyaK28zptVGisw%3D%3D 8797497
17. Nyhan WL, Ozand PT (1998) Atlas of metabolic diseases. Chapman and Hall, London, pp 76-78
18. B Seminotti G Leipnitz AU Amaral, et al. 2008 Lysine induces lipid and protein damage and decreases reduced glutathione concentrations in brain of young rats Int J Dev Neurosci 26 693 698 1:CAS:528:DC%2BD1cXht1SiurrE 10.1016/j.ijdevneu.2008.07.011 18691648
19. AM Tonin GC Ferreira PF Schuck, et al. 2009 Inhibition of creatine kinase activity by lysine in rat cerebral cortex Metab Brain Dis 24 349 360 1:CAS:528:DC%2BD1MXlvV2it7k%3D 10.1007/s11011-009-9131-z 19370404
20. A García-Cazorla D Rabier G Touati, et al. 2006 Pyruvate carboxylase deficiency: metabolic characteristics and new neurological aspects Ann Neurol 59 121 127 10.1002/ana.20709 16278852 (Pubitemid 43042878)
21. ME Steenweg GS Salomons Z Yapici, et al. 2009 L-2-Hydroxyglutaric aciduria: pattern of MR imaging abnormalities in 56 patients Radiology 251 856 865 10.1148/radiol.2513080647 19474378
22. O Braissant 2010 Current concepts in the pathogenesis of urea cycle disorders Mol Genet Metab 100 S3 S12 1:CAS:528:DC%2BC3cXks1Shurk%3D 10.1016/j.ymgme.2010.02.010 20227314
23. I Marin-Valencia CR Roe JM Pascual 2010 Pyruvate carboxylase deficiency: mechanisms, mimics and anaplerosis Mol Genet Metab 101 9 17 1:CAS:528: DC%2BC3cXhtVehsbzL 10.1016/j.ymgme.2010.05.004 20598931
24. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. Academic Press, San Diego
25. V Vasques F Brinco CM Viegas, et al. 2006 Creatine prevents behavioral alterations caused by methylmalonic acid administration into the hippocampus of rats in the open field task J Neurol Sci 244 23 29 1:CAS:528: DC%2BD28XjvVGmtbw%3D 10.1016/j.jns.2005.12.005 16457851
26. F Sigala S Theocharis K Sigalas, et al. 2006 Therapeutic value of melatonin in an experimental model of liver injury and regeneration J Pineal Res 40 270 279 1:CAS:528:DC%2BD28XislKktLo%3D 10.1111/j.1600-079X.2005.00310.x 16499564 (Pubitemid 43344663)
27. + -ATPase activity in hippocampus of rats subjected to acute administration of homocysteine is prevented by vitamins E and C treatment Neurochem Res 27 1685 1689 1:CAS:528:DC%2BD38XpsFCju78%3D 10.1023/A: 1021647329937 12515323 (Pubitemid 36020123)
28. + -ATPase inhibition induced by intracerebroventricular administration of isovaleric acid in cerebral cortex of young rats Brain Res 1262 81 88 1:CAS:528:DC%2BD1MXjt1Slt7k%3D 10.1016/j.brainres.2009.01.005 19210957
29. DH Jones AI Matus 1974 Isolation of synaptic plasma membrane from brain by combined flotation-sedimentation density gradient centrifugation Biochim Biophys Acta 356 276 287 1:CAS:528:DyaE2cXls1GrtLg%3D 10.1016/0005-2736(74) 90268-5 4367725
30. P Evelson M Travacio M Repetto, et al. 2001 Evaluation of total reactive antioxidant potential (TRAP) of tissue homogenates and their cytosols Arch Biochem Biophys 388 261 266 1:CAS:528:DC%2BD3MXitlOjt7c%3D 10.1006/abbi.2001. 2292 11368163 (Pubitemid 32911618)
31. 2 formation from labeled substrates by rat cerebral cortex Biochem Soc Trans 23 228S 1:CAS:528:DyaK2MXmsVOmsro%3D 7672249
32. BP Hughes 1962 A method for the estimation of serum creatine kinase and its use in comparing creatine kinase and aldolase activity in normal and pathological sera Clin Chim Acta 7 597 603 1:CAS:528:DyaF3sXhsFKnsg%3D%3D 10.1016/0009-8981(62)90137-7 13955534
33. CG da Silva ARF Bueno PF Schuck, et al. 2004 Inhibition of creatine kinase activity from rat cerebral cortex by D-2-hydroxyglutaric acid in vitro Neurochem Int 44 45 52 10.1016/S0197-0186(03)00098-6 12963087 (Pubitemid 37101142)
34. +)-stimulated ATPase and acetylcholinesterase activities of dog brain synaptosomal plasma membranes Biochem J 220 301 307 1:CAS:528:DyaL2cXktVaqsbs%3D 6331412
35. 2+-stimulated ATPase activity Anal Biochem 157 375 380 1:CAS:528:DyaL28XlvVKgtL0%3D 10.1016/0003-2697(86)90640-8 2946250
36. K Yagi 1998 Simple procedure for specific assay of lipid hydroperoxides in serum or plasma Methods Mol Biol 108 107 110 1:CAS:528:DyaK1cXlsFGhsLw%3D 9921520
37. RW Browne D Armstrong 1998 Reduced glutathione and glutathione disulfide Methods Mol Biol 108 347 352 1:CAS:528:DyaK1cXlsFGhtrs%3D 9921543
38. A Wendel 1981 Glutathione peroxidase Meth Enzymol 77 325 332 1:CAS:528:DyaL38XhtFOrur0%3D 10.1016/S0076-6879(81)77046-0 7329310
39. H Aebi 1984 Catalase, in vitro Meth Enzymol 105 121 126 1:CAS:528:DyaL2cXltVKis7s%3D 10.1016/S0076-6879(84)05016-3 6727660
40. Marklund SL (1985) Pyrogallol autoxidation. In: Greenwald RA (ed) Handbook of methods for oxygen radical research. CRC Press, Boca Raton, pp 243-247
41. SF Leong JB Clark 1984 Regional enzyme development in rat brain. Enzymes associated with glucose utilization Biochem J 218 131 138 1:CAS:528: DyaL2cXhtVSmu7w%3D 6712609
42. OH Lowry NJ Rosebrough A Lewis-Farr, et al. 1951 Protein measurement with the Folin phenol reagent J Biol Chem 193 265 275 1:CAS:528:DyaG38XhsVyrsw%3D%3D 14907713
43. +-dependent adenosine triphosphate system Biochem J 146 713 722 1:CAS:528:DyaE2MXksFGhtLk%3D 125082
44. M Erecinska IA Silver 1994 Ions and energy in mammalian brain Prog Neurobiol 43 37 71 1:CAS:528:DyaK2cXmsFWqs7s%3D 10.1016/0301-0082(94)90015-9 7972852 (Pubitemid 24221854)
45. M Erecinska S Cherian IA Silver 2004 Energy metabolism in mammalian brain during development Prog Neurobiol 73 397 445 1:CAS:528:DC%2BD2cXmslamtb0%3D 10.1016/j.pneurobio.2004.06.003 15313334 (Pubitemid 39099270)
46. +-ATPase activity during human trophoblast cell culture Eur J Biochem 206 881 885 1:CAS:528:DyaK38Xks1OnsL0%3D 10.1111/j.1432-1033.1992.tb16996.x 1318838
47. +-ATPase activity Mol Pharmacol 44 129 141 1:CAS:528:DyaK3sXlslCjur4%3D 8393517
48. SS Kamboj K Chopra R Sandhir 2009 Hyperglycemia-induced alterations in synaptosomal membrane fluidity and activity of membrane bound enzymes: beneficial effect of N-acetylcysteine supplementation Neuroscience 162 349 358 1:CAS:528:DC%2BD1MXotFChtrs%3D 10.1016/j.neuroscience.2009.05.002 19426784
49. P Rustin A Rötig 2002 Inborn errors of complex II-unusual human mitochondrial diseases Biochim Biophys Acta 1553 117 122 1:CAS:528: DC%2BD38XmsFGqug%3D%3D 10.1016/S0005-2728(01)00228-6 11803021 (Pubitemid 34137064)
50. MI Yousef HA El Hendy FM El-Demesdash, et al. 2002 Dietary zinc deficiency induced-changes in the activity of enzymes and the level of free radicals, lipids and protein electrophoretic behavior in growing rats Toxicology 175 223 234 1:CAS:528:DC%2BD38XktFKht78%3D 10.1016/S0300-483X(02)00049-5 12049850 (Pubitemid 34615716)
51. +)-stimulated adenosine triphosphatase J Biol Chem 249 1071 1080
52. MY Abeywardena TM Allen JS Charnock 1983 Lipid-protein interactions of reconstituted membrane-associated adenosine triphosphatases Biochim Biophys Acta 729 62 74 1:CAS:528:DyaL3sXhslGnt7k%3D 10.1016/0005-2736(83)90456-X 6131692
53. Halliwell B, Gutteridge JMC (2007) Cellular responses to oxidative stress: adaptation, damage, repair, senescence and death. In: Halliwell B, Gutteridge JMC (eds) Free radicals in biology and medicine. Oxford University Press Inc, Oxford, pp 187-267
54. M Martin M Macias G Escames, et al. 2000 Melatonin but not vitamins C and E maintains glutathione homeostasis in t-butyl hydroperoxide-induced mitochondrial oxidative stress FASEB J 14 1677 1679 1:CAS:528: DC%2BD3cXmsFGqurk%3D 10973915
55. D Acuña-Castroviejo G Escames M Macías, et al. 1995 Cell protective role of melatonin in the brain J Pineal Res 19 57 63 10.1111/j.1600-079X.1995.tb00171.x 8609597
56. RJ Reiter D Melchiorri E Sewerynek, et al. 1995 A review of the evidence supporting melatonin's role as an antioxidant J Pineal Res 18 1 11 1:CAS:528:DyaK2MXksFSmsr8%3D 10.1111/j.1600-079X.1995.tb00133.x 7776173
57. RJ Reiter JM Guerrero G Escames, et al. 1997 Prophylactic actions of melatonin in oxidative neurotoxicity Ann NY Acad Sci 825 70 78 1:CAS:528:DyaK2sXns1Olt74%3D 10.1111/j.1749-6632.1997.tb48415.x 9369975
58. JM Saudubray D Rabier 2007 Biomarkers identified in inborn errors for lysine, arginine, and ornithine J Nutr 137 1669S 1672S 1:CAS:528: DC%2BD2sXmt1ertL8%3D 17513445
59. + pump in epilepsy Ann Neurol 16 S128 S134 1:CAS:528:DyaL2cXmt1Ortro%3D 10.1002/ana.410160719 6095737 (Pubitemid 15202063)
60. Y Benari 1985 Limbic seizure and brain damage produced by kainic acid-mechanisms and relevance to human temporal lobe epilepsy Neuroscience 14 375 403 1:CAS:528:DyaL2MXhs1WmsbY%3D 10.1016/0306-4522(85)90299-4 (Pubitemid 15169910)
61. GJ Lees A Lehmann M Sandberg, et al. 1990 The neurotoxicity of ouabain, a sodium-potassium ATPase inhibitor in the rat hippocampus Neurosci Lett 120 159 162 1:CAS:528:DyaK3MXhtlGktb0%3D 10.1016/0304-3940(90)90027-7 1705675
62. E Satoh Y Nakazato 1992 On the mechanism of ouabain-induced release of acetylcholine from synaptosomes J Neurochem 58 1038 1044 1:CAS:528: DyaK38XhsVCmt7s%3D 10.1111/j.1471-4159.1992.tb09359.x 1737982
63. GJ Lees 1993 Contributory mechanisms in the causation of neurodegenerative disorders Neuroscience 54 287 322 1:CAS:528:DyaK3sXlsFOjurg%3D 10.1016/0306-4522(93)90254-D 8336826 (Pubitemid 23153743)
64. GJ Lees W Leong 1995 The sodium-potassium ATPase inhibitor ouabain is neurotoxic in the rat substantia nigra and striatum Neurosci Lett 188 113 116 1:CAS:528:DyaK2MXkvVaksrw%3D 10.1016/0304-3940(95)11413-Q 7540738
65. WJ Zinnanti J Lazovic 2010 Mouse model of encephalopathy and novel treatment strategies with substrate competition in glutaric aciduria type I Mol Genet Metab 100 88 91 10.1016/j.ymgme.2010.02.022
66. +-ATPase activity in cerebral cortex of rats Neuroreport 11 2331 2334 1:CAS:528:DC%2BD3cXls1OjtbY%3D 10.1097/00001756-200007140-00052 10923695
67. +-ATPase activity induced by homocysteine is probably mediated by oxidative stress Neurochem Res 26 1195 1200 1:CAS:528:DC%2BD38XhslOksL0%3D 10.1023/A:1013907104585 11874200 (Pubitemid 34171689)
68. +-ATPase activity in midbrain of rats subjected to arginine administration Neurochem Res 26 515 520 1:CAS:528:DC%2BD3MXmt1Sks7c%3D 10.1023/A:1010912929042 11513478 (Pubitemid 32744302)
69. +-ATPase activity in hippocampus of rats subjected to chemically induced hyperhomocysteinemia Neurochem Res 27 1593 1598 1:CAS:528: DC%2BD38XpsFCjtbY%3D 10.1023/A:1021670607647 12515310 (Pubitemid 36020111)